These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39117949)

  • 1. Esaxerenone, organ protection without sympathetic activation.
    Kawakami-Mori F
    Hypertens Res; 2024 Oct; 47(10):2923-2925. PubMed ID: 39117949
    [No Abstract]   [Full Text] [Related]  

  • 2. Esaxerenone: blood pressure reduction and cardiorenal protection without reflex sympathetic activation in salt-loaded stroke-prone spontaneously hypertensive rats.
    Ikeda S; Shinohara K; Kashihara S; Matsumoto S; Yoshida D; Nakashima R; Ono Y; Matsushima S; Tsutsui H; Kinugawa S
    Hypertens Res; 2024 Aug; 47(8):2133-2143. PubMed ID: 38802501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the drug-induced activation and deprivation of the sympathetic nervous system on aldosterone receptor binding by the kidney with disturbed neurotrophic support].
    Akimov IuA; Grishchenko AI; Rodionov AA
    Izv Akad Nauk Ser Biol; 1993; (1):145-9. PubMed ID: 8471966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subfornical organ lesions on sympathetic nerve responses to insulin.
    Muntzel MS; Thunhorst RL; Johnson AK
    Hypertension; 1997 Apr; 29(4):1020-4. PubMed ID: 9095093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eprosartan modulates the reflex activation of the sympathetic nervous system in sodium restricted healthy humans.
    Vase H; Lauridsen TG; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 2008 Jun; 65(6):822-32. PubMed ID: 18341678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central sympathetic inhibition by mineralocorticoid receptor but not angiotensin II type 1 receptor blockade: are prescribed doses too low?
    Leenen FH; Ruzicka M; Floras JS
    Hypertension; 2012 Aug; 60(2):278-80. PubMed ID: 22733463
    [No Abstract]   [Full Text] [Related]  

  • 7. Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients.
    Raheja P; Price A; Wang Z; Arbique D; Adams-Huet B; Auchus RJ; Vongpatanasin W
    Hypertension; 2012 Aug; 60(2):319-25. PubMed ID: 22733474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic activation in cardiovascular and renal disease.
    Grassi G; Arenare F; Pieruzzi F; Brambilla G; Mancia G
    J Nephrol; 2009; 22(2):190-5. PubMed ID: 19384835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat.
    MacNeil BJ; Jansen AH; Greenberg AH; Nance DM
    Brain Behav Immun; 2003 Dec; 17(6):442-52. PubMed ID: 14583236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microneurography: technique to study cardiovascular regulation by the sympathetic nervous system in humans].
    Mion Júnior D; Abrahão S; Tinucci T; Marcondes M; Krieger E
    Rev Assoc Med Bras (1992); 1994; 40(3):189-94. PubMed ID: 7787870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sympathy and heartache: new information on the sympathetic nervous system].
    Spieker LE; Binggeli C; Lüscher TF; Noll G
    Schweiz Med Wochenschr; 1997 Nov; 127(48):1986-92. PubMed ID: 9490465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists and sympathetic nerve activation: are there differences between classes?
    Noll G; Wenzel RR; Shaw S; Lüscher TF
    J Hypertens Suppl; 1998 Jan; 16(1):S17-24. PubMed ID: 9534092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of neurogenic dystrophies induced by activation and deprivation of the sympathetic nervous system].
    Akimov IuA; Kositsyn NS
    Izv Akad Nauk Ser Biol; 2005; (2):226-31. PubMed ID: 16004286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone-induced brain MAPK signaling and sympathetic excitation are angiotensin II type-1 receptor dependent.
    Zhang ZH; Yu Y; Wei SG; Felder RB
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H742-51. PubMed ID: 22081704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
    Pfitzer T; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Pharmacokinetics and Pharmacodynamics of Esaxerenone, a Novel Mineralocorticoid Receptor Antagonist: A Review.
    Janković SM; Janković SV
    Eur J Drug Metab Pharmacokinet; 2022 May; 47(3):291-308. PubMed ID: 35190999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of insulin action on sympathetic nerve activity.
    Muntzel MS; Anderson EA; Johnson AK; Mark AL
    Clin Exp Hypertens; 1995; 17(1-2):39-50. PubMed ID: 7735284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous adenosine contributes to renal sympathetic neurotransmission via postjunctional A1 receptor-mediated coincident signaling.
    Jackson EK; Cheng D; Tofovic SP; Mi Z
    Am J Physiol Renal Physiol; 2012 Feb; 302(4):F466-76. PubMed ID: 22114202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
    Kumagai H; Suzuki H; Ichikawa M; Matsumura Y; Jimbo M; Ryuzaki M; Saruta T
    Circ Res; 1993 Jun; 72(6):1255-65. PubMed ID: 8495554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.